Cite
HARVARD Citation
Reid, T. et al. (n.d.). The direct NLRP3 inhibitor and Phase 3 small molecule anticancer agent, RRx‐001, protects aged triple transgenic Alzheimer's disease model mice from CNS degeneration and cognitive decline. Alzheimer's & dementia. p. n/a. [Online].